HEALTHCARE Archives - Page 2 of 4

USFDA Approves Empagliflozin, Metformin Hydrochloride Tablets to Zydus Lifesciences

Neha VermaJuly 11, 2022September 1, 2022

by Neha VermaJuly 11, 2022September 1, 202201138

The United States Food and Drug Administration (USFDA) approves Zydus Lifescience for Empagliflozin and Metformin Hydrochloride Tablets in 5 mg/500 mg, 5 mg/1000 mg, 12.5...

HEALTHCARE

Bajaj Allianz Launches Product to Provide Global Health Insurance Coverage

NileshJune 29, 2022

by NileshJune 29, 202201162

On June 28, Bajaj Allianz General Insurance announced the launch of a global healthcare product that provides medical coverage to its policyholders worldwide. In a...

HEALTHCARE

Sanofi, GSK Covid-19 Vaccine Found Effective Against Omicron

NileshJune 24, 2022

by NileshJune 24, 202201382

On June 24, the French drugmaker said that late-stage data from Sanofi and GlaxoSmithKline’s experimental Covid-19 vaccine showed it could protect against the Omicron variant...

HEALTHCARE

Monkeypox Declared Pandemic by World Health Network

NileshJune 23, 2022June 23, 2022

by NileshJune 23, 2022June 23, 202201165

The World Health Network (WHN) has declared the current monkeypox outbreak a pandemic after 58 countries reported 3,417 confirmed cases. The outbreak is spreading rapidly...

HEALTHCARE

Glenmark Pharma Launches Asthma Drug Indamet

NileshJune 16, 2022June 16, 2022

by NileshJune 16, 2022June 16, 202201589

On Thursday, Glenmark Pharmaceuticals said it had launched a new Fixed-Dose Combination (FDC) drug in the country to treat patients with uncontrolled asthma. The Mumbai-based...

HEALTHCARE

Alembic Gets USFDA Approval for Cancer Treatment Drug

NileshJune 10, 2022

by NileshJune 10, 202201474

Alembic Pharmaceuticals said in a statement it had received approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Dasatinib tablets of 20...

HEALTHCARE

Lupin Gets Generic Drug Approval from USFDA

NileshJune 8, 2022June 8, 2022

by NileshJune 8, 2022June 8, 202201145

Drugmaker Lupin said on Wednesday it had received preliminary approval from US health regulators to sell Ivacaftor tablets for cystic fibrosis in the US. In...

HEALTHCARE

Zydus Receives USFDA Approval for Generic Antacid

NileshJune 6, 2022June 6, 2022

by NileshJune 6, 2022June 6, 202201223

On Monday, Zydus Lifesciences said that it had received final approval from US health regulators to market its antacid famotidine tablets in the US market....

HEALTHCARE

Alembic Pharma Gets FDA Approval for Pirfenidone Tablets

NileshMay 24, 2022May 24, 2022

by NileshMay 24, 2022May 24, 202201089

Alembic Pharmaceuticals rose 1.03 per cent to Rs 768.20 after the company announced that it’s Abbreviated New Drug Application (ANDA) for pirfenidone tablets had received...

HEALTHCARE

Akums Drugs Get Indian License to Manufacture Bempedoic Acid for Heart Disease

NileshMay 23, 2022May 23, 2022

by NileshMay 23, 2022May 23, 202201439

Akums Drugs and Pharmaceuticals has licensed the manufacture and commercialisation of bempedoic acid, a lipid-lowering drug for heart disease patients. Orally administered by statin-intolerant patients,...

EquityPandit

Category : HEALTHCARE

USFDA Approves Empagliflozin, Metformin Hydrochloride Tablets to Zydus Lifesciences

Bajaj Allianz Launches Product to Provide Global Health Insurance Coverage

Sanofi, GSK Covid-19 Vaccine Found Effective Against Omicron

Monkeypox Declared Pandemic by World Health Network

Glenmark Pharma Launches Asthma Drug Indamet

Alembic Gets USFDA Approval for Cancer Treatment Drug

Lupin Gets Generic Drug Approval from USFDA

Zydus Receives USFDA Approval for Generic Antacid

Alembic Pharma Gets FDA Approval for Pirfenidone Tablets

Akums Drugs Get Indian License to Manufacture Bempedoic Acid for Heart Disease

EquityPandit